The potential benefits of stem cell-based technology in Factorfive anti-aging skin care has parent company Xytogen Biotech Inc. in a bit of a bind, forcing it to keep the capability of products under wraps to avoid drug claims.
“We are in a funny catch-22,” said John Aylworth, founder and CEO of the San Jose, CA-based firm during a 24 October interview. “If we validate the claims that we’d...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?